Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Coronavirus disease 2019 (COVID-19) vaccines are being developed and implemented with unprecedented speed. Accordingly, trials considered ethical at their inception may quickly become concerning. We provide recommendations for Data and Safety Monitoring Boards (DSMBs) on monitoring the ethical acceptability of COVID-19 vaccine trials, focusing on placebo-controlled trials in low- and middle-income countries.

More information

DOI

10.1093/cid/ciab239

Type

Journal article

Publication Date

06/12/2021

Volume

73

Pages

2126 - 2130

Total pages

4

Keywords

COVID-19 vaccines, SARS-CoV-2, clinical trials data monitoring committees, ethics, research, standard of care, COVID-19, COVID-19 Vaccines, Clinical Trials Data Monitoring Committees, Humans, SARS-CoV-2, Vaccines